Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments
Launched by UNIVERSITAT INTERNACIONAL DE CATALUNYA · Jun 6, 2024
Trial Information
Current as of November 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to dental implants called immediate implants, which are placed right after a tooth is removed. The goal is to see if using special temporary pieces, known as individualized healing abutments, can help maintain the surrounding bone and gum tissue better than traditional methods. This could mean shorter treatment times and fewer surgeries for patients.
To participate in this trial, you need to be an adult at least 25 years old who requires the removal of a specific tooth in the back of your mouth (molars or premolars). You also need to have enough healthy gum and bone tissue to support the implant. If you are a non-smoker or a light smoker (less than 10 cigarettes a day) and do not have any serious health issues, you might be eligible. Participants will receive the implant and be closely monitored throughout the healing process to assess how well the tissue responds. It's important to note that certain conditions, like an active infection or severe bone loss, could prevent you from joining the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient ( 25 years old).
- • Need for extraction of an irrational tooth to be treated in the molar/premolar position of the upper/lower arch.
- • Presence of 2mm of keratinized gingiva.
- • Bone dehiscence in the alveolar walls of 2 mm. 2 mm.
- • Adequate amount of bone in the interradicular septum to stabilize the implant (minimum height 10 mm, minimum width 4 mm at the base of the septum).
- • Plaque index (FMSPI, full mouth score plaque index) \< 10%.
- • Non-smokers or smokers of less than 10 cigarettes per day.
- • Absence of systemic diseases that contraindicate implant surgery.
- Exclusion Criteria:
- • Presence of alveoli with dehiscence \>2mm.
- • Presence of adjacent implants.
- • \< 2mm of keratinized gingiva.
- • Presence of active infection (fistula, suppuration) at the extraction site.
- • Presence of apical granuloma \>2mm in diameter in the root(s) of the tooth or teeth to be extracted.
- • Residual bone apical to the extraction insufficient to anchor the implant.
- • Pregnant or lactating women.
- • Severe cognitive or psychiatric disorders.
- • Compromised general health status ( ASA IV).
- • Use of drugs that alter bone metabolism and healing.
- • Absence of manual primary stability of the implant
- • Bone dehiscence or fenestration after implant placement (manual rotation).
- • Gap 2mm between the implant and the vestibular bone wall.
About Universitat Internacional De Catalunya
The Universitat Internacional de Catalunya (UIC) is a prestigious higher education institution situated in Barcelona, Spain, renowned for its commitment to academic excellence and innovation in research. With a strong emphasis on interdisciplinary collaboration, UIC actively engages in clinical trials that aim to advance medical knowledge and improve patient outcomes. The university's dedicated research teams are equipped with cutting-edge facilities and experienced professionals, enabling them to conduct rigorous studies across various health-related fields. UIC's focus on ethical practices and compliance ensures that all clinical trials are conducted with the highest standards of scientific integrity and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, Catalonia, Spain
Patients applied
TD
CW
AG
Trial Officials
Matteo Albertini, PhD
Principal Investigator
Universidad Internacional de Catalunya
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported